Aust N Z J Psychiatry:发现创伤后应激障碍高危患者潜在影像学标志

2019-04-13 不详 上海交大

近日,上海交通大学医学院附属精神卫生中心王振研究团队与附属仁济医院影像科合作在Australian & New Zealand Journal of Psychiatry杂志在线发表题为Cortical surface area reduction in identification of subjects at high risk for post-traumatic stress disord

近日,上海交通大学医学院附属精神卫生中心王振研究团队与附属仁济医院影像科合作在Australian & New Zealand Journal of Psychiatry杂志在线发表题为Cortical surface area reduction in identification of subjects at high risk for post-traumatic stress disorder:  A pilot study的研究论文,首次报道左侧岛叶、左侧前扣带回喙部皮层表面积小是创伤后应激障碍(Post-traumatic Stress Disorder, PTSD)高危患者的潜在生物学标志,研究将为PTSD早期识别、早期干预提供依据。

PTSD是个体在经历创伤性事件后延迟出现、并持续存在的一种精神障碍。交通事故是日常生活中最常见的创伤性事件,相当一部分经历交通事故者会出现不同程度的心理障碍,其中PTSD是最常见且影响巨大的一种疾病,该病不但治疗难度大,且复发率高,社会功能损害严重。相关研究表明:创伤事件发生后尽早进行临床干预可显着降低PTSD发病率。因此,早期识别、早期干预就对PTSD而言显得意义重大。

该课题组对交通事故伤者进行了磁共振结合临床评估的前瞻性研究,在研究基线纳入交通事故48小时内的伤者,进行磁共振结构像扫描,同时采集临床相关数据。通过6月临床随访,通过临床诊断评估工具,评估PTSD的发生情况。该研究中共70例被试完成临床随访,其中29例伤者发展为PTSD,41例伤者未发展为PTSD。PTSD组被试在交通事故发生时左侧岛叶、左侧前扣带回喙部皮层表面积即显着小于未发展为PTSD的被试。

原始出处:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1955773, encodeId=42a31955e73f8, content=<a href='/topic/show?id=5b0b1022667b' target=_blank style='color:#2F92EE;'>#高危患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102266, encryptionId=5b0b1022667b, topicName=高危患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Fri Sep 06 13:52:00 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1792144, encodeId=72191e9214487, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Thu Oct 17 17:52:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335258, encodeId=272b133525874, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Mon Apr 15 00:52:00 CST 2019, time=2019-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1445277, encodeId=ff0c14452e7f5, content=<a href='/topic/show?id=61e74928629' target=_blank style='color:#2F92EE;'>#应激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49286, encryptionId=61e74928629, topicName=应激)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79df5138909, createdName=ms1260584454294838, createdTime=Mon Apr 15 00:52:00 CST 2019, time=2019-04-15, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1955773, encodeId=42a31955e73f8, content=<a href='/topic/show?id=5b0b1022667b' target=_blank style='color:#2F92EE;'>#高危患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102266, encryptionId=5b0b1022667b, topicName=高危患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Fri Sep 06 13:52:00 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1792144, encodeId=72191e9214487, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Thu Oct 17 17:52:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335258, encodeId=272b133525874, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Mon Apr 15 00:52:00 CST 2019, time=2019-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1445277, encodeId=ff0c14452e7f5, content=<a href='/topic/show?id=61e74928629' target=_blank style='color:#2F92EE;'>#应激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49286, encryptionId=61e74928629, topicName=应激)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79df5138909, createdName=ms1260584454294838, createdTime=Mon Apr 15 00:52:00 CST 2019, time=2019-04-15, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1955773, encodeId=42a31955e73f8, content=<a href='/topic/show?id=5b0b1022667b' target=_blank style='color:#2F92EE;'>#高危患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102266, encryptionId=5b0b1022667b, topicName=高危患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Fri Sep 06 13:52:00 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1792144, encodeId=72191e9214487, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Thu Oct 17 17:52:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335258, encodeId=272b133525874, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Mon Apr 15 00:52:00 CST 2019, time=2019-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1445277, encodeId=ff0c14452e7f5, content=<a href='/topic/show?id=61e74928629' target=_blank style='color:#2F92EE;'>#应激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49286, encryptionId=61e74928629, topicName=应激)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79df5138909, createdName=ms1260584454294838, createdTime=Mon Apr 15 00:52:00 CST 2019, time=2019-04-15, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1955773, encodeId=42a31955e73f8, content=<a href='/topic/show?id=5b0b1022667b' target=_blank style='color:#2F92EE;'>#高危患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102266, encryptionId=5b0b1022667b, topicName=高危患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Fri Sep 06 13:52:00 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1792144, encodeId=72191e9214487, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Thu Oct 17 17:52:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335258, encodeId=272b133525874, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Mon Apr 15 00:52:00 CST 2019, time=2019-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1445277, encodeId=ff0c14452e7f5, content=<a href='/topic/show?id=61e74928629' target=_blank style='color:#2F92EE;'>#应激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49286, encryptionId=61e74928629, topicName=应激)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79df5138909, createdName=ms1260584454294838, createdTime=Mon Apr 15 00:52:00 CST 2019, time=2019-04-15, status=1, ipAttribution=)]

相关资讯

Lancet Planetary Health:经历洪水会如何影响精神健康?

研究发现经历洪水会影响精神健康,在洪水发生后一年,搬迁人群(因洪水)和未搬迁人群中抑郁症、焦虑和创伤后应激障碍的发生率是否存在差异?

研究发现18岁以下青少年中有8%患有创伤后应激障碍

发表在"柳叶刀精神病学 "(The Lancet Psychiatry)一项新研究显示,有十三分之一的18岁以下青少年患有创伤后应激障碍(PTSD)。

Psychoneuroendocrinology:中科院心理所发现促食欲激素系统影响创伤后应激障碍症状

促食欲激素是指一类能够调节促进食欲的激素。日前,中国科学院心理研究所科研团队首次发现了促食欲激素系统对创伤后应激障碍症状的影响。相关研究成果已经发表于国际心理神经内分泌学会会刊。

J Abnorm Child Psych:张建新研究组揭示创伤后应激障碍临床症状结构的跨性别稳定性及其与行为问题之间的差异性关联

在2013年公布的美国《精神障碍诊断与统计手册》第五版(简称DSM-5)中,专家组基于实证研究与临床经验对创伤后应激障碍(Posttraumatic stress disorder,PTSD)的临床症状标准进行了多项修改,由此引发了研究者们关于PTSD临床症状结构的新一轮探讨。逐渐积累起来的研究证据大多来自成人样本,它们为DSM-5界定的4维表型模型以及基于该模型修正而成的5维DSM-5精神痛苦性

J Child Psychol Psyc:儿童创伤后应激障碍不容忽视

患有创伤后应激障碍(PTSD)的儿童和青少年可以只用几个小时的EMDR或认知行为写作治疗(CBWT)就成功治疗。这是阿姆斯特丹大学(UVA)和儿童和青年创伤中心(GGZ Rivierduinen)的一项新研究发现。这篇论文于6月29日星期四发表在《儿童心理学与精神病学杂志》上。

Tonix停止对Tonmya进行军事相关创伤后应激障碍(PTSD)的后期研究

Tonix制药表示正停止对Tonmya(一种舌下含服的环苯扎林片状透明胶囊制剂)进行III期HONOR研究,Tonmya起初用于治疗军事相关的创伤后应激障碍(PTSD)。根据Tonix的说法,一项中期分析显示,在第12周,主要终点与安慰剂分离不足。